About the Marsha Rivkin Center - Working Group Meeting

The most critical problems in ovarian cancer research are identified and discussed, resulting in important scientific collaborations. The meetings are open to all researchers, physicians, post-docs and advocates in the field of ovarian cancer.

Upcoming Meetings:

Aug 8, 2006

Piri Welcsh, PhD (Univ. of Washington)
Title: "Pilot Study Final Report: Epigenetic Profiling of Ovarian Cancer with High-Density Microarrays"

Aug 22, 2006

Cassian Yee, MD (FHCRC)
Title: "Pilot Study Final Report: Identification of T cell-defined Antigens in Ovarian Cancer"

Members & Recent Presentations:

Jul 11, 2006

Nicole Urban, ScD and Charles Drescher, MD (FHCRC)
Title: "Early Lesion Discovery Project"
And Nathalie Scholler, MD, PhD (FHCRC)
Title: "Development of a CA125-Mesothelin Cell Adhesion Assay as a Screening Tool for Biologics Discovery"

Jun 27, 2006

Saul Rivkin, MD (Swedish Medical Center & Marsha Rivkin Center)
Title: "ASCO Update"

Jun 13, 2006

Judeth Bianco, RPh, PhD (Novartis)
Title: "Preclinical and Clinical Overview of Patupilone (EPO906) : A Novel Epothilone Currently in Phase III Trials for Refractory/Resistant Ovarian Cancer"

May 23, 2006

Saul Rivkin, MD (Swedish Medical Center & Marsha Rivkin Center)
Title: "Evaluation of New Ovarian Cancer Markers in Relation to Clinical Practice and Early Relapse"

May 9, 2006

Nicole Urban, ScD; Charles Drescher, MD and Michel Schummer, PhD (FHCRC)
Title: "HE4 staining of prophylactic oophorectomy specimens"

Apr 25, 2006

Apr 11, 2006

Sarah Holt, MPH (Univ. of Washington)
Title: "Ovarian Cancer Risk and Polymorphisms Involved in Estrogen Catabolism - Final Report"

Mar 28, 2006

Jen-Tsan Ashley Chi (Duke University)
Title: "Genomic Analysis of Hypoxia Phenotypes in Human Cancers"

Mar 14, 2006

Charles Drescher (FHCRC)
Discussion: Recent Early Detection Publications

Feb 28, 2006

Ingegerd Hellstrom, MD, PhD (UW)
Title: "Preliminary studies on Ovarian Carcinoma Stem cells"

Feb 14, 2006

Nicole Urban, ScD and Charles Drescher, MD (FHCRC)
Title: TBD

Jan 24, 2006

Tony Blau, MD (UW)
Title: TBD

Jan 10, 2006

Barbara Goff, MD (Univ of Washington) and Robyn Andersen, PhD (FHCRC)
Final Report: Ovarian Cancer Symptom Study

Dec 27, 2005

Dec 13, 2005

Robyn Andersen, PhD (FHCRC)
Title: TBD

Nov 22, 2005

Muneesh Tewari, MD, PhD (FHCRC)
Title: "Networks, tumor robustness and evolution: potential relevance to cancer biology and therapy"

Nov 8, 2005

Hootie Warren, MD, PhD (FHCRC)
Title: "A polymorphic oncofetal antigen recognized by CD8+ CTL from two patients with metastatic RCC responding to nonmyeloablative allogeneic HCT."

Oct 25, 2005

Update: 13th Annual SPORE Meeting (Baltimore, WA)
Discussion led by Saul Rivkin, MD (Swedish Medical Center)

Oct 11, 2005

Marci Schaner, PhD (Pfizer)
Title: "Update of Genomic Profiling in Ovarian Cancer"

Sep 27, 2005

Update: Helene Harris Memorial Trust Conference
Discussion Led by Nicole Urban, ScD (FHCRC)

Sep 13, 2005

Zsolt Petko, MD (FHCRC)
Title: TBD

Aug 23, 2005

Andre Lieber, MD (Univ. of Washington)
Title: "Challenges for oncolytic virotherapy of ovarian cancer"

Aug 9, 2005

Ruey-Min Lee, PhD (Huntsman Cancer Institute, Univ of Utah)
Title: "Induction of cell death by targeting mitochondrial proteins as a novel cancer therapy"

Jul 26, 2005

Prof. Michal Linial (Hebrew Univ. of Jerusalem & Visiting Professor at UW)
Title: "Snapshots of living cells - A Bioinformatics Approach"

Jul 12, 2005

June 28, 2005

Robert Resta, MS, CGC (SMC)
Title: "Screening for BRCA Mutations in Ashkenazi Jews: A Possible Research Project"

June 7, 2005

David Huntsman (Univ. of British Columbia)
Study Final Report: EMSY amplification: clinical relevance in ovarian cancer

May 17, 2005

Bruce Montgomery, MD (VA Puget Sound)
Title: TBD

May 3, 2005

Daniela Dinulescu, PhD (MIT Center for Cancer Research)
Title: "Genetic Models of Endometriosis and Ovarian Cancer"

Apr 19, 2005

Beatrice Knudsen, PhD (FHCRC)
Title: "Identifying the cellular origin of serous ovarian cancer: Expression profiles associated with early ovarian carcinogenesis"

Apr 5, 2005

Ellen Pizer, MD (SMC) and Pamela Paley, MD (SMC)
Discussion: "Pilot Project for Detection of Early Pathologic and Molecular Alterations"

Mar 15, 2005

Ellen Pizer, MD (SMC)
Title: "Precursor lesions of serous carcinoma"

Mar 1, 2005

Title: "Oral contraceptives in reducing the risk of ovarian cancer in BRCA positive women"
Discussion led by Robert Resta

Feb 15, 2005

Saul Rivkin, MD (SMC & MRC)
Title: "Update on Oncovue: A Risk Assessment Product"

Feb 1, 2005

Irena King, PhD (FHCRC)
Title: "The Role of N-3 (Omega-3) Fatty Acids on Ovarian Cancer Progression and Survival"

Jan 18, 2005

Irena King, PhD (FHCRC)
Title: "The Effect of N-3 (Omega-3) Fatty Acids on Ovarian Cancer Recurrence/Progression"

Jan 4, 2005

Charles Drescher, MD (FHCRC & MRC)
Title: "The Marsha Rivkin Center Ovarian Cancer Screening Program- a proposal"

Dec 21, 2004

Dec 7, 2004

Nathalie Scholler, MD, PhD (FHCRC)*
Title: TOR Lab Update
* Dr. Hanash will be rescheduling for February

Nov 16, 2004

Toshiyasu Taniguchi, MD, PhD (FHCRC)
Title: "The Fanconi Anemia-BRCA Pathway in Cancer"

Nov 2, 2004

Jeff Ross, MD (Millennium Pharmaceuticals Inc.)
Title: "Emerging Molecular Diagnostics and Targets of Therapy in Ovarian Cancer"

Oct 19, 2004

Literature Discussion: BRCA and ovarian cancer

Oct 5, 2004

Sep 21, 2004

Dr. Hua Mu (Abraxis Oncology)
Topic: Nano-Particle Technology

Sep 7, 2004

Nicole Urban, ScD & Charles Drescher, MD
Screening Studies: Future Plans

Aug 17, 2004

Discussion Topic: RNA Extraction (Continued)

Aug 3, 2004

Discussion Topic: RNA Extraction
Papers available by contacing Jocelyn Moore at jocelyn.moore@swedish.org.

Jul 20, 2004

Saul Rivkin, MD (SMC & MRC)
Discussion: 12th Annual SPORE Meeting Review

Jul 6, 2004

Biaoyang Lin, PhD
Title: "Identification of chemotherapy response related proteins in ovarian cancer by a proteomics approach"

June 15, 2004

Brad Stone, PhD (Benaroya Research Center, Virginia Mason)
Title: TBD

June 1, 2004

Kathy O'Briant, MS (FHCRC)
Title: "Preliminary Luminex Results"

May 18, 2004

Jeff Ledbetter, PhD (Trubion Inc.)
Title: "Genes and Gene Delivery Systems for Cancer Therapy"

April 20, 2004

Shaoyi Jiang, PhD (UW)
Title: "Surface Plasmon Resonance Biosensor for Medical Diagnostics"

April 6, 2004

Irena King, PhD (FHCRC)
Title: "Ovarian Cancer Recurrence -
What's fat got to do with it?"

March 16, 2004

Alvin Liu, PhD (Institute of Systems Biology)
Title: "Prostate Cell Lineages"

March 2, 2004

Brad Stone, PhD (VM)
Title: TBD

February 17, 2004

Daniel Egger (Factorial Diagnostics)
Title: TBD

February 3, 2004

Discussion: "Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2," King et al, Science, Vol 302 pp643 - 646.
Discussion led by Robert Resta, MS, CGC
(Swedish Medical Center)
Please contact Jocelyn Moore at jocelyn.moore@swedish.org for copies of article.

January 20, 2004

Anna Lokshin, PhD (Univ. of Pittsburgh)
Title: "Multiplex Serum Assay for Early Detection of Ovarian Cancer"

December 16, 2003

Dominic Andrada M.S. (Bio-Rad Labs)
Title: "BioPlex: Multiplexed Protein Flow Cytometric Analysis "

December 2, 2003

Ellen Pizer, MD (Swedish Medical Center)
Title: TBD

November 18, 2003

Daniel O'Shannessy, MD (Fujirebio Diagnostics)
Title: Progress towards the early detection of ovarian cancer

November 4, 2003

Kathryn McGonigle, MD (Virginia Mason)
Title: Surgical management of ovarian cancer

October 21, 2003

Michél Schummer, PhD (MacroGenics)
Title: Molecular Profiling of Ovarian Tissues

October 7, 2003

Patrice Morin, PhD (National Institutes of Health)
Title: Expression profiling in ovarian cancer: identification of novel genes and pathways for diagnosis and therapy

September 16, 2003

Sharon Moran, MD (Virginia Mason)
Title: Microarray expression analysis of human tumor antigens in ovarian cancer

September 2, 2003

Eric Lynch, PhD (Vice-President, Sound Pharmaceuticals, Inc.)
Title: "Chemoprotection from cisplatin induced hearing loss"

August 19, 2003

Lupe Salazar, MD (Univ. of Washington)
Title: "Phase I study evaluating the safety of three doses of intraperitoneal DAB389IL-2 (ONTAK) administered to patients with advanced stage ovarian cancer"

*Specially Scheduled Working Group Meeting*
August 12, 2003

Thomas Herzog, MD (Washington Univ. School of Medicine)
Title: "New Directions in the Treatment of Ovarian Cancer"
This meeting is sponsored by GlaxoSmithKline. Continental breakfast will be provided.

August 5, 2003

Andre Lieber, MD, PhD (Univ. of Washington)
Title: "Oncolytic adenoviruses for treatment of metastatic cancer"

*Special Working Group Meeting*
Jul 29, 2003

David Curiel, MD (Univ. of Alabama at Birmingham)
Title: "Strategies to adapt adenovirus for cancer therapy application"

Jul 15, 2003

Jul 1, 2003

Charles Drescher, MD (FHCRC)
Title: "Using Molecular Profiling for Selecting Therapy"

June 17, 2003

Nicole Urban, ScD (FHCRC)
Title: "Design Issues in Chemoprevention Trials in Ovarian Cancer"

June 3, 2003

Denise C. Connolly, Ph.D. (Fox Chase Cancer Center)
Title: "Modeling epithelial ovarian cancer in mice"

May 20, 2003

Eleftherios P. Diamandis MD, PhD, FRCPC (University of Toronto)
Title: "Presentation of Kallikrein Family of Markers and Their Role in Ovarian Cancer"

May 6, 2003

Howard Muntz, MD (Virginia Mason Medical Center)
Title: "Intraperitoneal Consolidation Therapy for Advanced Ovarian Cancer"

April 15, 2003

Toni Kline, PhD (Seattle Genetics)
Title: "Matrix Metalloproteases for the Targeting and Release of Antitumor Agents"

Apr 1, 2003

Julianne Wojciak, MS, CGC (Myriad Genetic Laboratories)
Title: "Hereditary Breast and Ovarian Cancer: An Update of Recent Publications"

Mar 18, 2003

Barbara Goff, MD (UW) and Robyn Andersen, MPH, PhD (FHCRC)
Title: "Evaluating Symptoms as a Biomarker for Ovarian Cancer"

Mar 4, 2003

Qinghua Feng, PhD (UW)
Title: "Epigenetic Changes in Ovarian Cancer"

Feb 18, 2003

David Ralph, PhD & Craig Shimasaki, PhD (InterGenetics Inc., Oklahoma City, OK)
Title: "Statistical dissection of the role of genetics in determining risk of complex diseases"
For more information contact Jocelyn Moore at (206) 215-6202

Feb 4, 2003

Keith Knutson, MD (UW)
Title: "Immune-based approaches for the treatment and prevention of cancer"

Jan 21, 2003

Discussion:

Couzin, Jennifer, "Small RNAs Make Big Splash," Science vol 298, Dec 20, 2002 pp. 2296-2297.
Plasterk, Ronald, "RNA Silencing: The Genome's Immune System," Science vol 296, May 17, 2002 pp. 1263 - 1265.

Please contact Jocelyn Moore at jocelyn.moore@swedish.org or (206) 215-6202 to request copies of articles

Jan 7, 2003

Udo Schmeidl, MD (SMC)
Title: "RFA (Radio Frequency Ablation) of liver masses"

Dec 10, 2002

Mark Murray (Protiva Inc., Vancouver, BC)
Title: "Tumor-Selective Gene Expression and Anti-tumor Activity Following Systemic Gene Delivery with Stable Plasmid Lipid Particles"

Nov 26, 2002

Shahram Vaezy, PhD (UW)
Title: "Tumor Treatment using High Intensity Focused Ultrasound"

Nov 12, 2002

Neli Ulrich, PhD (FHCRC)
Concept proposal: "Pharmacogenetics of platinum-based therapy in ovarian cancer patients"

Oct 29, 2002

Brad Nelson, PhD (VMRC) & Ingegerd Hellstrom, MD, PhD (PNRI)
Mouse Models for Ovarian Carcinoma

Oct 15, 2002

Biaoyang Lin (Institute for Systems Biology)
A systems approach to study the androgen-response program in prostate cancer cells

Oct 1, 2002

Richard Kneirim, MD (SMC)
"Mucinous Neoplasms of the Ovary"

Sept 17, 2002

Dr. Roohangiz Safaei (Univ. of Calif. San Diego)
"ID of Organelles and Molecules Invovled in Cisplatin Resistance in Ovarian Cancer Cells"

Sept 3, 2002

Charles Drescher & Nicole Urban (FHCRC, MRC)
Strategic Planning for the Marsha Rivkin Center

August 20, 2002

Larry Kessler, ScD (FHCRC Visiting Scientist & FDA)
"Regulatory Requirements for Genetic Tests and Biomarkers"

August 6, 2002

Michèl Schummer, PhD (MacroGenics)
"Towards clinical applications of genes found to be associated with chemoresistance in ovarian cancer"

June 25, 2002

Ingegerd Hellstrom, MD, PhD (PNRI)
"Approaches to tumor vaccination"

June 11, 2002

Patty Theiss, PhD (VMRC)
"CD4+ CD8+ T cells specific for epitopes expressed in mice ovarian tumors do not proliferate after encountering the ovarian tumor in vivo"

May 28, 2002

Cassian Yee, MD (FHCRC & UW)
"Adoptive T Cell Therapy of Cancer"

May 14, 2002

Karin Rodland & Colleagues (PNNL)
"Pacific Northwest National Laboratories Proteomics Capabilities, Plasma Proteome Project scFV Antibody Capability, Development of Bead Based Assays, Mass Spectrometry and Biochemical Separations"

April 30, 2002

Robyn Andersen, PhD, MPH (FHCRC)
"Quality of Life Intervention for Breast and Ovarian Cancer Patients"

April 16, 2002

Mark Hannibal, MD, PhD (Univ. of Wash.)
"Replacing high-dose cytotoxic agents by allogeneic graft versus host effects in the cure of cancer"

April 2, 2002

Martin McIntosh, PhD (FHCRC) & Nicole Urban, ScD (FHCRC)
Discussion: "Use of proteomic patterns in serum to identify ovarian cancer." Lancet 359: 572 - 577, 2002 Feb 16.

March 19, 2002

David Paisley, MD (Swedish Medical Center)
"PET scans and the evaluation of ovarian cancer patients"

March 5, 2002

Rainer Storb, MD (FHCRC)
"Replacing high-dose cytotoxic agents by allogeneic graft versus host effects in the cure of cancer"

February 19, 2002

Discussion & Planning: "4th Biennial Ovarian Cancer Symposium: Sept 19 - 20, 2002"

February 5, 2002

Alan Wahl, PhD and Nathalie Scholler, MD, PhD (Seattle Genetics)
"Antibody-targeted therapies for cancer"

January 22, 2002

Paul Weiden, MD & Jelle Kylstra, MD (Dendreon Corporation)
"HER2 Targeted Cellular Therapies in Ovarian and Breast Cancer"

January 8, 2002

Discussion: Shridhar V, et. al.
"Genetic analysis of early- versus late-stage ovarian tumors." Cancer Research. 61(15):5895-904, 2001 Aug 1.

Working Group Meeting

Marsha Rivkin Center Working Group